EPIRUS Biopharmaceuticals
EPIRUS Biopharmaceuticals (Nasdaq:EPRS) is a pure-play biosimilar company focused on the global development and commercialization of biosimilar monoclonal antibodies (mAbs). EPIRUS' goal is to improve...load more
EPIRUS Biopharmaceuticals's Basic Information
Industry
Headquarters
Boston, Georgia, United States
Website
Founded Year
2013
Headcount
11 - 50 ( View All )
EPIRUS Biopharmaceuticals's Competitors
Employee Insights
EPIRUS Biopharmaceuticals's Top Employees
Cheryl Lassen
Vice President Clinical Development
Phone Email
Markus Mühlemann
Director International Controller
Phone Email
Remco Brandt
Head of Business Operations NL
Phone Email
Peter Simons
Director, Antibody Development
Phone Email
Manfred Saller
Director DSP
Phone Email
Frequently Asked Questions Regarding EPIRUS Biopharmaceuticals
Where is EPIRUS Biopharmaceuticals's headquarter located?
EPIRUS Biopharmaceuticals's headquarter are located at United States.
How many employees does EPIRUS Biopharmaceuticals have?
EPIRUS Biopharmaceuticals has 11 - 50 employees.
What is EPIRUS Biopharmaceuticals's official website?
EPIRUS Biopharmaceuticals's official website is http://epirusbiopharma.com
What does EPIRUS Biopharmaceuticals do?
EPIRUS Biopharmaceuticals (Nasdaq:EPRS) is a pure-play biosimilar company focused on the global development and commercialization of biosimilar monoclonal antibodies (mAbs). EPIRUS' goal is to improve...
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts